Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Interview: Tim Clover, Rayner

HBI catches up with Tim Clover, CEO of UK-based ophthalmic medical products specialist Rayner, ahead of his appearance as a panellist at HBI 2022. He is excited about the Covid bounceback and hot new tech, but warns new regulations will impact heavily on everyone's costs.
March 31, 2022

HBI Deals+Insights briefing April 2022: Deals+Insights members

Click here to see your Deals+Insights briefing for April 2022 April's edition delves into how “for sale” Fresenius is creating a new $2.4bn business, asks if record results for Synlab could precipitate a Cinven sale, and sees Ramsay make an eye-watering bid for GHP. Interviews include Dagmar Dvorakova, CEO and Prof. Dr. Roland Staudinger, managing […]
March 29, 2022

Infermedica targets the USA for expansion

Infermedica, the Polish health tech start-up, will expand its US investments, thanks to the funding gained in a recent Series B financing round. HBI talks with Miłosz Wiciński, Business Development Executive at Infermedica, to learn more.
March 25, 2022

For-profit oncology consolidation in Europe

This week, we look at the extent to which the for-profit oncology market is consolidated in four major European markets – France, Germany, UK and Spain. These figures are a snapshot of the position based on revenues in 2020 taken from HBI Intelligence. 
March 24, 2022

Doctolib France’s biggest Unicorn

Now the largest unicorn in France, Doctolib is valued at €5.8b, three years after it reached unicorn status, despite still making a loss. HBI speaks to a French healthcare consultant and expert to find out how.
March 24, 2022

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
March 24, 2022

Unilabs sale completes

AP Moller Holding, the investment company owned by the billionaire Maersk family, has closed the purchase of global lab and imaging chain Unilabs. 
March 23, 2022

Icade Sante considering H2 for IPO attempt part deux

At the end of last year, healthcare specialist REIT Icade Santé looked to fall victim to capital markets' apathy for European healthcare services, postponing its IPO. Could it be looking to try again in H2 2022 - or is it too soon to try?
March 23, 2022

Circle Health sponsors work visas for Ukrainian refugees fleeing war

For-profit UK hospital groups are working on their responses to the humanitarian crisis in Ukraine. Circle Health is to sponsor up to 500 work visas for Ukrainian refugees across its 54 sites in the UK. We find out more about the plan, and approach other large providers in the UK to find out what they are doing.
March 23, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us